ArticlePharmaceuticals (Basel, Switzerland)2026
Timing of Evolocumab Initiation After Acute Coronary Syndrome and Long-Term Lipid and Cardiovascular Outcomes: A Multicenter Real-World Cohort Study.
Lama Alfehaid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.